Brian Holmes, who has been battling metastatic prostate cancer, underwent the pioneering treatment at Derriford Hospital ...
Monte Rosa Therapeutics (NasdaqGS:GLUE) announced a new supply agreement with Johnson & Johnson to evaluate MRT-2359 with ERLEADA in metastatic castration resistant prostate cancer. The company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results